Characterization of a novel humanized monoclonal antibody specific to KAL 006: Impact on lymphatic metastasis in cancer
Cancer cells can travel to distant sites through the lymphatic system; this system is similar to a network of pipes within the body that carries fluids and cells to all organs. The metastatic spread of cancer cells through this network is one of the reasons why this disease is so difficult to stop. We are working with Kalgene Pharmaceuticals to test a new compound that can impact the lymphatic system. The hope is to block this network and thus stop metastatic spread thereby improving patient survival. We in partnership with Kalgene will provide the scientific and technical expertise in order to push this new compound to the clinic.